FIA
NUVB icon

FNY Investment Advisers’s Nuvation Bio NUVB Stock Holding History

FNY Investment Advisers’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,000
Closed -$19K – 1427
2025
Q2 		$19K Buy
+10,000
New +$20.8K 0.01% 562
2021
Q1 		– Sell
-40,000
Closed -$468K – 949
2020
Q4 		$468K Buy
+40,000
New +$416K 0.13% 139

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

FNY Investment Advisers's NUVB Position: Q3 2025 in Review

FNY Investment Advisers sold out of Nuvation Bio (NUVB) in Q3 2025, closing a stake of 10,000 shares — an estimated $19K sold.

FNY Investment Advisers first reported a position in NUVB in Q4 2020 and held it in 2 quarters. The position peaked at $468K in Q4 2020. 203 funds tracked by Wall St. Rank hold NUVB as of Q3 2025.

  • FNY Investment Advisers reported no remaining Nuvation Bio position as of Q3 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 10,000 Nuvation Bio shares in Q3 2025, an estimated $19K.
  • FNY Investment Advisers first reported a position in Nuvation Bio in Q4 2020 and held it in 2 quarters.
  • FNY Investment Advisers's Nuvation Bio position peaked at $468K in Q4 2020.
  • 203 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2025.

Based on FNY Investment Advisers's 13F filing for Q3 2025, filed 15 Dec 2025.